Indeed, in lung squamous cell carcinoma, an anti‐PD‐1 antibody (pembrolizumab) plus chemotherapy including platinum‐based compounds improves overall survival.31 The gene discussed is PDCD1; the disease is squamous cell lung carcinoma.